Firebrick Pharma Ltd
ASX:FRE
Balance Sheet
Balance Sheet Decomposition
Firebrick Pharma Ltd
Firebrick Pharma Ltd
Balance Sheet
Firebrick Pharma Ltd
| Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
1
|
0
|
1
|
7
|
2
|
1
|
1
|
|
| Cash |
1
|
0
|
1
|
7
|
2
|
1
|
1
|
|
| Total Receivables |
1
|
1
|
1
|
1
|
0
|
1
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
1
|
2
|
8
|
3
|
2
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
1
-44%
|
2
+169%
|
9
+396%
|
3
-66%
|
2
-19%
|
2
-24%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+171%
|
0
-19%
|
0
+110%
|
1
+13%
|
0
-43%
|
0
-7%
|
|
| Equity | ||||||||
| Common Stock |
2
|
3
|
6
|
16
|
17
|
18
|
20
|
|
| Retained Earnings |
1
|
2
|
4
|
8
|
15
|
16
|
18
|
|
| Total Equity |
1
N/A
|
0
-64%
|
2
+296%
|
8
+436%
|
2
-70%
|
2
-15%
|
2
-26%
|
|
| Total Liabilities & Equity |
1
N/A
|
1
-44%
|
2
+169%
|
9
+396%
|
3
-66%
|
2
-19%
|
2
-24%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
169
|
169
|
169
|
169
|
176
|
176
|
225
|
|